Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Luessi

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Neurology|July 21, 2005
Clinical studies with transdermal rotigotine in early Parkinson's diseaseW Poewe, F Luessi
International Journal of Andrology|December 17, 2008
Re: Hypergonadotropic hypogonadism in a patient with inv ins (2;4)F Luessi, J Sollors, J Knabe, et al.
Journal of the Neurological Sciences|November 22, 2011
Influence of visual cues on gait in Parkinson's disease during treadmill walking at multiple velocitiesF Luessi, L K Mueller, M Breimhorst, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 27, 2019
Vemurafenib and cobimetinib combination therapy for BRAFV600E-mutated melanoma favors posterior reversible encephalopathy syndromeS Engel, F Luessi, B Henning, et al.
Der Nervenarzt|August 14, 2015
[Current aspects of therapy conversion for multiple sclerosis]P Kolber, F Luessi, S G Meuth, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Neurology|July 21, 2005
Clinical studies with transdermal rotigotine in early Parkinson's diseaseW Poewe, F Luessi
International Journal of Andrology|December 17, 2008
Re: Hypergonadotropic hypogonadism in a patient with inv ins (2;4)F Luessi, J Sollors, J Knabe, et al.
Journal of the Neurological Sciences|November 22, 2011
Influence of visual cues on gait in Parkinson's disease during treadmill walking at multiple velocitiesF Luessi, L K Mueller, M Breimhorst, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 27, 2019
Vemurafenib and cobimetinib combination therapy for BRAFV600E-mutated melanoma favors posterior reversible encephalopathy syndromeS Engel, F Luessi, B Henning, et al.
Der Nervenarzt|August 14, 2015
[Current aspects of therapy conversion for multiple sclerosis]P Kolber, F Luessi, S G Meuth, et al.
Pageof 1